Showing 30 of 3541 posts
Tullow Oil slashes debt to $1.1B via $380M asset sales & 2025 refinancing. Analysis of Gabon exit, Kenya divestment, and Ghana focus.
JoshuaMay 22, 2025
Johnson Matthey returns £1.4bn to shareholders after £1.8bn Catalyst sale. Strategic shift to clean air & PGM services for cash growth.
JoshuaMay 22, 2025
Energean Israel Q1 2025: 22.5% profit dip offset by $2B gas contracts amid Middle East tensions. Analysis of risks & resilience.
JoshuaMay 22, 2025
QinetiQ's £1.54bn defence contract extension offsets £90.5m FY25 loss. Strategic restructuring targets 15-20% EPS growth by 2026. Full analysis here.
JoshuaMay 22, 2025
Central Asia Metals acquires New World Resources in a $185m deal, gaining Arizona's high-grade Antler Copper Project to boost US critical minerals expansion.
JoshuaMay 21, 2025
Amcomri's post-IPO results reveal 23.4% revenue growth to £58.1m & 33% EBITDA surge, powered by strategic acquisitions & margin gains.
JoshuaMay 20, 2025
Newmark Security's HCM drives 67% revenue (14% YoY growth) via Oracle/SAP partnerships, with 24% ARR surge to £3.6m. Strategic analysis inside.
JoshuaMay 20, 2025
41% production surge & $440m debt: Nostrum's Q1 2025 reveals strategic shifts with Stepnoy Leopard development & Ural O&G partnership.
JoshuaMay 20, 2025
Vodafone FY25: UK merger synergies, African growth surge & German challenges analysed. Strategic shifts under Della Valle's leadership decoded.
JoshuaMay 20, 2025
Xeros Tech Group partners with IFB & Russell Hobbs, slashes losses, eyes breakeven. B Corp innovator tackles microplastics ahead of EU 2028 filter mandate.
JoshuaMay 20, 2025
Transense partners with ISI (Molex) to enable US-made SAW sensors for defence & aerospace, securing CHIPS Act-compliant growth in strategic markets.
JoshuaMay 20, 2025
Calnex Solutions FY25: Profit rebound as 800Gb/s tech & cloud/defence deals drive 1,339% EBITDA surge. Full turnaround analysis.
JoshuaMay 20, 2025
Luceco's Q1 2025 update: 19% revenue surge to £61m, driven by EV charging growth and stable margins. Confident outlook maintained despite economic caution.
JoshuaMay 20, 2025
Caledonia Investments celebrates 58-year dividend growth streak and proposes 10:1 share split to boost retail appeal while navigating market challenges.
JoshuaMay 20, 2025
SSP Group maintains FY guidance as H1 meets targets. Analysis of resilient travel sector performance, restructuring plans & India IPO potential.
JoshuaMay 20, 2025
Poolbeg Pharma's POLB 001 Phase 2 in cancer immunotherapy & oral GLP-1 for obesity. AI pipeline, Friel's leadership & 2026 catalysts analysed.
JoshuaMay 20, 2025
TruFin boosts 2025 forecasts to £51m revenue & £8m EBITDA, launches £4m share buyback as Balatro gaming success drives growth. Analysis inside.
JoshuaMay 20, 2025
Bromford Flagship reports £214m surplus post-merger, secures top G1/V1 rating. Affordable housing growth meets robust financial stability in sector-leading results.
JoshuaMay 20, 2025
AstraZeneca's £800m EsoBiotec acquisition pioneers IV-administered cell therapies targeting cancer and autoimmune diseases via revolutionary ENaBL platform.
JoshuaMay 20, 2025
Topps Tiles posts 3.2% profit growth after CMA resolution. Strategic gains in trade digital, B2B & new categories. £365m sales target.
JoshuaMay 20, 2025
LondonMetric's FY25: 17.6% dividend growth, 120% EPRA earnings surge & 99% occupancy. Logistics & triple-net lease strategy insights.
JoshuaMay 20, 2025
Jadestone Energy 2024: Record production & revenue growth, lower debt. 2025 guidance maintained. Strategic focus on core assets & gas projects.
JoshuaMay 20, 2025
Ithaca Energy boosts Cygnus stake to 85% in £116M deal. Adds 23mmboe reserves, powers 1.5M UK homes. Strategic play for UK energy security & gas production growth.
JoshuaMay 20, 2025
Unicorn AIM VCT reports 6.9% NAV dip but declares 3p dividend and £24.1m fundraising success. Insights into UK small-cap challenges and portfolio moves.
JoshuaMay 20, 2025
Genuit maintains full-year outlook with 8.5% revenue growth to £199.3m amid UK recovery signs and sustainability focus.
JoshuaMay 19, 2025
Arecor & Skye Bioscience partner to develop nimacimab, an obesity drug with improved formulation & less frequent dosing via Arestat™ tech.
JoshuaMay 19, 2025
Cerillion H1 2025: 23% backlog surge to £56.5m & 20% dividend hike offset 7% revenue dip. Recurring revenue up 8%.
JoshuaMay 19, 2025
SDI Group's FY25 forecasts met through strong H2 momentum and King's Award-winning acquisitions. Cash-rich engineering play eyes strategic growth.
JoshuaMay 19, 2025
Aurrigo's 34% revenue surge & 433% autonomous growth lead aviation innovation. Schiphol & UPS partnerships signal major airport tech disruption. Read more.
JoshuaMay 19, 2025
Kainos FY25: Revenue dips 4%, but AI surges 61% & Workday Products up 24%. Restructuring fuels product growth & global expansion. Key insights for investors.
JoshuaMay 19, 2025